US Advisers Reject Wider Stryker Corporation ‘s Bone Putty Use

Reuters - Stryker Corp’s (SYK.N) bone-growth putty for spinal surgery should not be approved for expanded use in a wider population, advisors to federal drug regulators said on Tuesday.

MORE ON THIS TOPIC